This was the stock's second consecutive day of losses.

Shares of Kenvue rose in early Thursday trading after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter ...

Kenvue on Thursday forecast that its annual profit would be flat year-over-year as the consumer health firm anticipates a ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new ...

Kenvue Inc. maintained its sales expectations for the year while lowering its profitability target as tariffs raise costs.

The leadership change comes at the end of a week in which the California-based toymaker landed squarely in the crosshairs of ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

(Reuters) -Kenvue beat analysts' expectations for first-quarter profit and revenue on Thursday, as strong demand for its self ...

(Reuters) -Kenvue beat quarterly profit and revenue estimates on Thursday as better-than-expected demand for cough-and-cold ...

Sysco sells and distributes food and related products to customers and has been increasing its dividend for 56 years. Johnson ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $23.00. The company’s shares closed last Fr ...